59 related articles for article (PubMed ID: 24797980)
21. Increased serum concentration of ceramides in obese children with nonalcoholic fatty liver disease.
Wasilewska N; Bobrus-Chociej A; Harasim-Symbor E; Tarasów E; Wojtkowska M; Chabowski A; Lebensztejn DM
Lipids Health Dis; 2018 Sep; 17(1):216. PubMed ID: 30208901
[TBL] [Abstract][Full Text] [Related]
22. Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss.
Reinehr T; Roth CL
J Clin Endocrinol Metab; 2008 Nov; 93(11):4479-85. PubMed ID: 18728159
[TBL] [Abstract][Full Text] [Related]
23. Serum concentration of adiponectin, leptin and resistin in obese children with non-alcoholic fatty liver disease.
Lebensztejn DM; Wojtkowska M; Skiba E; Werpachowska I; Tobolczyk J; Kaczmarski M
Adv Med Sci; 2009; 54(2):177-82. PubMed ID: 20022856
[TBL] [Abstract][Full Text] [Related]
24. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
25. Serum Fetuin-A levels in obese children with biopsy proven nonalcoholic fatty liver disease.
Pampanini V; Inzaghi E; Germani D; Alterio A; Puglianiello A; Alisi A; Nobili V; Cianfarani S
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):71-76. PubMed ID: 29122442
[TBL] [Abstract][Full Text] [Related]
26. Serum fetuin A concentration is elevated in children with non-alcoholic fatty liver disease.
Lebensztejn DM; Białokoz-Kalinowska I; Kłusek-Oksiuta M; Tarasów E; Wojtkowska M; Kaczmarski M
Adv Med Sci; 2014 Mar; 59(1):81-4. PubMed ID: 24797980
[TBL] [Abstract][Full Text] [Related]
27. Is liver transaminases assessment an appropriate tool for the screening of non-alcoholic fatty liver disease in at risk obese children and adolescents?
Rodríguez G; Gallego S; Breidenassel C; Moreno LA; Gottrand F
Nutr Hosp; 2010; 25(5):712-7. PubMed ID: 21336425
[TBL] [Abstract][Full Text] [Related]
28. Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.
Amacher DE
Biomarkers; 2014 Nov; 19(7):541-52. PubMed ID: 25189636
[TBL] [Abstract][Full Text] [Related]
29. [The role of fetuin-A in cardiovascular diseases].
Vörös K; Cseh K; Kalabay L
Orv Hetil; 2014 Jan; 155(1):16-23. PubMed ID: 24379092
[TBL] [Abstract][Full Text] [Related]
30. The Evolving Role of Fetuin-A in Nonalcoholic Fatty Liver Disease: An Overview from Liver to the Heart.
Dogru T; Kirik A; Gurel H; Rizvi AA; Rizzo M; Sonmez A
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34205674
[TBL] [Abstract][Full Text] [Related]
31. Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists.
Mann JP; Goonetilleke R; McKiernan P
Arch Dis Child; 2015 Jul; 100(7):673-7. PubMed ID: 25633064
[TBL] [Abstract][Full Text] [Related]
32. Molecular and pathobiological involvement of fetuin-A in the pathogenesis of NAFLD.
Sardana O; Goyal R; Bedi O
Inflammopharmacology; 2021 Aug; 29(4):1061-1074. PubMed ID: 34185201
[TBL] [Abstract][Full Text] [Related]
33. Fetuin-A: a novel link between obesity and related complications.
Trepanowski JF; Mey J; Varady KA
Int J Obes (Lond); 2015 May; 39(5):734-41. PubMed ID: 25468829
[TBL] [Abstract][Full Text] [Related]
34. Pediatric Non-alcoholic Fatty Liver Disease.
Uppal V; Mansoor S; Furuya KN
Curr Gastroenterol Rep; 2016 May; 18(5):24. PubMed ID: 27086005
[TBL] [Abstract][Full Text] [Related]
35. [Research advances in pediatric nonalcoholic fatty liver disease].
Dai DL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jan; 17(1):107-12. PubMed ID: 25616307
[TBL] [Abstract][Full Text] [Related]
36. Non-alcoholic fatty liver disease: a brief review.
van Hoek B
Scand J Gastroenterol Suppl; 2004; (241):56-9. PubMed ID: 15696851
[TBL] [Abstract][Full Text] [Related]
37. Steatohepatitis in children.
Roberts EA
Best Pract Res Clin Gastroenterol; 2002 Oct; 16(5):749-65. PubMed ID: 12406443
[TBL] [Abstract][Full Text] [Related]
38. Nonalcoholic fatty liver disease.
Alfire ME; Treem WR
Pediatr Ann; 2006 Apr; 35(4):290-4, 297-9. PubMed ID: 16637558
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
